SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001562180-22-005353
Filing Date
2022-06-24
Accepted
2022-06-24 16:51:24
Documents
1
Period of Report
2022-06-23

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primarydocument.html 4  
1 PRIMARY DOCUMENT primarydocument.xml 4 6137
  Complete submission text file 0001562180-22-005353.txt   7670
Mailing Address 700 PARK OFFICES DRIVE SUITE 200 RESEARCH TRIANGLE PARK NC 27709
Business Address 700 PARK OFFICES DRIVE SUITE 200 RESEARCH TRIANGLE PARK NC 27709 919-213-9835
G1 Therapeutics, Inc. (Issuer) CIK: 0001560241 (see all company filings)

IRS No.: 263648180 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O TESARO, INC. 1000 WINTER STREET, SUITE 3300 WALTHAM MA 02451
Business Address
Nicholson Garry A (Reporting) CIK: 0001640861 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38096 | Film No.: 221040741